New drug access for PFIC patients in Japan!
Exciting news for PFIC and Alagille syndrome patients in Japan! Maralixibat was recently approved by the Japanese Ministry of Health, Labour, and Welfare for the treatment of cholestatic pruritus. Congratulations to the Mirum Pharmaceuticals team!